Healthcare M&A Trends Q3 2026: PPM Slows as State Notice Laws and Federal MSO Scrutiny Arrive
Healthcare M&A stayed steady in Q3 2026, but physician practice management (PPM) deals slightly declined as state corporate-practice-of-medicine and “mini-HSR” transaction-notice laws lengthened timelines and higher financing costs weighed on valuations, according to Bass, Berry & Sims. The firm says investors are proceeding selectively rather than retreating. Federal scrutiny of PE-backed MSO arrangements arrived for the first time with the Stop Corporate Takeovers of Physicians Act of 2026, introduced in September. PE sponsors also faced strategic buyers: McKesson agreed to acquire Precision Medicine Group for about $2.25 billion, and a Warburg Pincus-led group agreed to buy control of PANTHERx Rare in a deal reportedly above $7 billion.
Operators and sponsors building or exiting MSO-backed platforms should plan for longer closing timelines, advance state notice filings and possible federal legislation, and should expect competition from strategic buyers on larger deals.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
What happened to physician practice management deal activity in Q3 2026?
Bass, Berry & Sims says PPM deal activity was generally steady but slightly declined, as new advance transaction notice requirements in several states and high interest rates pressured deal economics. Investors are proceeding selectively.
What federal bill targets PE-backed MSO arrangements?
In September 2026, federal lawmakers introduced the Stop Corporate Takeovers of Physicians Act of 2026. Bass Berry describes it as the first time scrutiny of PE-backed MSO arrangements reached the federal level.
Which Q3 2026 transactions does the report highlight?
McKesson’s agreement to acquire Precision Medicine Group for about $2.25 billion, Sanford Health’s partnership with North Memorial Health to form a 60-hospital system, and a Warburg Pincus-led group’s agreement to acquire control of PANTHERx Rare in a deal reportedly valued above $7 billion.